Latest Strategy News

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Alkane Resources reports its Q1 FY2026 interim results, highlighting the integration of Mandalay Resources and key operational developments across its global mining portfolio.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.

Matsa Resources has officially commenced gold production at its Devon Pit Gold Mine, marking a significant step forward in its Lake Carey Gold Project. With maiden reserves confirmed and a robust option agreement in place with AngloGold Ashanti, the company is poised for growth amid ongoing exploration success.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.

EBOS Group Limited has updated its Dividend Reinvestment Plan rules, offering shareholders new ways to reinvest dividends into additional shares. The changes, effective immediately, provide greater flexibility and maintain board discretion over share issuance terms.

City Chic Collective has reversed its fortunes with a $15 million EBITDA turnaround in FY25, driven by strategic restructuring and strong ANZ growth. The company eyes a debt-free 2025 close and cash flow positivity in FY26 amid cautious optimism for US market expansion.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Shaver Shop Group Limited reported a record gross margin of 45.5% and EBIT growth of 2.4% in FY25, alongside a strong fully franked dividend. The 2025 AGM saw shareholder approval of key governance items including executive incentives.

Chimeric Therapeutics reports promising interim results from its CHM CDH17 Phase 1/2 trial, with 75% disease control at 28 days and durable responses in gastrointestinal cancers.

Waratah Minerals has addressed a sharp share price drop and surge in trading volume, attributing the market activity to pending, incomplete exploration results at its Spur Gold-Copper Project.

Iltani Resources has reported compelling assay results from its VTEM-targeted drilling at the Orient Silver-Indium Project, revealing multiple thick zones of high-grade silver-lead-zinc-indium mineralisation. These findings validate VTEM as a powerful exploration tool and hint at a significant expansion of the existing resource.